QIAGEN NV (QIA MU) stock market data APIs
€38.4395
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
QIAGEN NV Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for QIA.MU.
Prev. Close
38.4395
Open
38.4395
High
38.4395
Low
38.4395
52 wk Range
32.9333-45.5153
Market Cap
10 941 M
EPS
0.55
Dividends (Yield)
0
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get QIAGEN NV data using free add-ons & libraries
Get QIAGEN NV Fundamental Data
QIAGEN NV Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 0.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
QIAGEN NV News
New
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026 Capital return to be conducted through synthetic share repurchase – combines a f...
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
Incyte INCY announced that the European Commission (EC) has approved a label expansion of Minjuvi (tafasitamab). The drug, in combination with Revlimid (lenalidomide) and rituximab, is now indicated ...
Are Investors Undervaluing Qiagen N.V. (NYSE:QGEN) By 24%?
Key Insights Qiagen's estimated fair value is US$59.85 based on 2 Stage Free Cash Flow to Equity Qiagen's US$45.44 share price signals that it might be 24% undervalued Analyst price target for QGEN i...
Companies Are Just Now Tallying Up the Impact of the US Shutdown
(Bloomberg) -- While the longest government shutdown in US history is over, the consequences of the 43-day impasse are only just starting to feed through for companies across the US and beyond. Firms...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
